Dr. Jeffrey Newcorn, MD
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Attention-Deficit/Hyperactivity Disorder (ADHD)
Studies Attention Deficit Hyperactivity Disorder (ADHD)
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Jeffrey Newcorn, MD is currently running
Methylphenidate
for ADHD
This trial is investigating how genetic differences in an enzyme called CES1 affect the way ADHD patients respond to the medication methylphenidate. The goal is to understand why some patients do not respond well or experience severe side effects. Methylphenidate (MPH) is a well-established treatment for ADHD, but not all patients respond to it, and some experience adverse reactions.
Recruiting3 awards Phase 4
Stimulant vs Non-stimulant Treatments
for ADHD
The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Recruiting3 awards Phase 49 criteria
More about Jeffrey Newcorn, MD
Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jeffrey Newcorn, MD has experience with
- Methylphenidate
- Atomoxetine
Breakdown of trials Jeffrey Newcorn, MD has run
Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Newcorn, MD specialize in?
Jeffrey Newcorn, MD focuses on Attention-Deficit/Hyperactivity Disorder (ADHD) and Attention Deficit Hyperactivity Disorder (ADHD). In particular, much of their work with Attention-Deficit/Hyperactivity Disorder (ADHD) has involved treating patients, or patients who are undergoing treatment.
Is Jeffrey Newcorn, MD currently recruiting for clinical trials?
Yes, Jeffrey Newcorn, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Newcorn, MD has studied deeply?
Yes, Jeffrey Newcorn, MD has studied treatments such as Methylphenidate, Atomoxetine.
What is the best way to schedule an appointment with Jeffrey Newcorn, MD?
Apply for one of the trials that Jeffrey Newcorn, MD is conducting.
What is the office address of Jeffrey Newcorn, MD?
The office of Jeffrey Newcorn, MD is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.